|
Persistent Identifier
|
perma:LIST.GAOXKU |
|
Publication Date
|
2026-07-06 |
|
Title
| Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study [* Cross-Reference *] |
|
Other Identifier
| https://doi.org/10.3390/brainsci13050736
OpenAlex ID: https://openalex.org/W4367310731 |
|
Author
| Odette Fründt (Klinikum Ernst von Bergmann)
Anne-Marie Hanff (University of Luxembourg, Maastricht University Medical Centre, Luxembourg Institute of Health, Luxembourg Institute of Science and Technology) - ORCID: https://orcid.org/0000-0002-8955-8697
Annika Möhl (Universität Hamburg, University Medical Center Hamburg-Eppendorf) - ORCID: https://orcid.org/0000-0003-3274-7216
Tobias Mai (Goethe University Frankfurt, University Hospital Frankfurt) - ORCID: https://orcid.org/0000-0003-3233-1763
Christiane Kirchner (Klinikum Ernst von Bergmann)
Ali Amouzandeh (Klinikum Ernst von Bergmann)
Carsten Buhmann (Universität Hamburg, University Medical Center Hamburg-Eppendorf) - ORCID: https://orcid.org/0000-0001-8540-3789
Rejko Krüger (Centre Hospitalier de Luxembourg, University of Luxembourg, Luxembourg Institute of Health) - ORCID: https://orcid.org/0000-0003-4258-6241
Martin Südmeyer (Düsseldorf University Hospital, Klinikum Ernst von Bergmann, Heinrich Heine University Düsseldorf) |
|
Point of Contact
|
Use email button above to contact.
LIST QDKM (LIST) |
|
Description
| Data on the use of device-aided therapies (DATs) in people with Parkinson’s disease (PwP) are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application frequency and type of DAT in a larger, nationwide, cross-sectoral PwP sample in Germany; (2) analyzed the frequency of symptoms indicative for advanced PD (aPD) and need for DAT amongst the remaining patients and (3) compared the most bothersome symptoms and need for professional long-term care (LTC) of patients with and without suspected aPD. Data from 1269 PwP were analyzed. In total, 153 PwP (12%) received DAT, mainly deep brain stimulation (DBS). Of the remaining 1116 PwP without DAT, >50% fulfilled at least one aPD criterion. Akinesia/rigidity and autonomic problems were most bothersome for PwP with and without suspected aPD, with more tremor in the non-aPD and more motor fluctuations and falls in the aPD group. To recapitulate, the German DAT application rate is rather low, although a large proportion of PwP fulfills aPD criteria indicating a need for intensified treatment strategies. Many reported bothersome symptoms could be overcome with DAT with benefits even for LTC patients. Thus, precise and early identification of aPD symptoms (and therapy-resistant tremor) should be implemented in future DAT preselection tools and educational trainings. (2023-04-28)
***This entry has been automatically imported via OpenAlex by LIST harvest scripts. Please refer to https://doi.org/10.3390/brainsci13050736 for the original and latest version of the publication*** (2026-07-01) |
|
Subject
| Medicine, Health and Life Sciences |
|
Keyword
| Parkinson's disease
German
Medicine
Disease
Psychology
Physical medicine and rehabilitation
Neuroscience
Internal medicine
History |
|
Topic Classification
| Parkinson's Disease Mechanisms and Treatments
Neurological disorders and treatments
Genetic Neurodegenerative Diseases |
|
Deposit Date
| 2023-04-28 |
|
Data Type
| Article |
|
Data Source
| Brain Sciences |